Processa Pharmaceuticals opened lower at $1.81, compared with its previous close of $1.87. In the last trading session, the stock traded between $1.80 and $1.91. It showed a downward intraday trend.
Return calculator
Time Period
An investment of $100 made 5 years ago in Processa Pharmaceuticals is now worth
$ 0.05
Resulting in a loss of
$ 99.95 (99.95%)
Invest with $1
Note: Past profits do not guarantee future returns.
Analyst Overview
No analyst rating data available.
Markets Today
Today's Change
$-0.04 (-2.14%)
Day High
$1.91
Day Low
$1.80
Day Open
$1.81
Prev Close
$1.87
Volume
15,227
1W Return
-6.30%
1M Return
-2.66%
3M Return
-30.81%
6M Return
-31.97%
1Y Return
-76.82%
Fundamentals
Market Cap ($ Mn)
5
PE Ratio
-
PB Ratio
-
PEG Ratio
-
ROE
-298.23%
ROCE
-300.63%
EPS (TTM)
$-1.17
Investment Returns
1 Week
-6.30%
1 Month
-2.66%
3 Months
-30.81%
6 Months
-31.97%
9 Months
-25.31%
Financials
Quarterly
All values in $ Mn
0.0
Dec 24
0.0
Mar 25
0.0
Jun 25
0.0
Sep 25
0.0
Dec 25
0.0
Jun 26
Updates
10Oct
Processa Pharmaceuticals files prospectus for 306.574M share sale
Processa Pharmaceuticals Inc filed a prospectus for a secondary offering. The offering comprises 306.574 million common shares. Shares are being sold by existing shareholders, not the company itself.
1mo ago
1Sep
Processa Pharmaceuticals to present at two investor conferences
Processa Pharmaceuticals to present at Wells Fargo and H.C. Wainwright conferences in September. Sheila Gujrathi, board member, will deliver presentations on the company's clinical-stage pipeline. Company completed acquisition of Vidya Therapeutics in July 2026 via stock-for-stock deal. Oversubscribed private placement raised approximately $200 million to fund operations. Lead asset VT-7208 targets immune-mediated diseases with Phase 2 data expected in 2027-2028.
